Page last updated: 2024-10-29

ketanserin and Fra(X) Syndrome

ketanserin has been researched along with Fra(X) Syndrome in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Fragile X syndrome is a common inherited form of mental retardation caused by the lack of fragile X mental retardation protein (FMRP) because of Fmr1 gene silencing."1.38Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndrome. ( Chen, GS; Li, XQ; Liu, G; Liu, SB; Ma, L; Wu, YM; Xu, ZH; Yang, Q; Zhao, MG, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, ZH1
Yang, Q1
Ma, L1
Liu, SB1
Chen, GS1
Wu, YM1
Li, XQ1
Liu, G1
Zhao, MG1

Other Studies

1 other study available for ketanserin and Fra(X) Syndrome

ArticleYear
Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndrome.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Fragile X Mental Retardation Pr

2012